Litcius/Paper detail

Inhibition of succinate dehydrogenase activity impairs human T cell activation and function

Claudia Nastasi, Andreas Willerslev-Olsen, Kristoffer Dalhoff, Shayne L. Ford, Anne‐Sofie Ø. Gadsbøll, Terkild B. Buus, Maria Gluud, Morten Danielsen, Thomas Litman, Charlotte M. Bonefeld, Carsten Geisler, Niels Ødum, Anders Woetmann

2021Scientific Reports45 citationsDOIOpen Access PDF

Abstract

T cell activation is intimately linked to metabolism, as distinct metabolic requirements support the functional and phenotypical differences between quiescent and activated T cells. Metabolic transition from mitochondrial oxidative phosphorylation to aerobic glycolysis is crucial for a proper T cell activation. However, the role of tricarboxylic acid cycle (TCA), and in particular succinate dehydrogenase (SDH) in activated T cells needs further elucidation. Here we show that inhibition of SDH during activation of T cells results in strong impairment of proliferation, expression of activation markers, and production of key inflammatory cytokines, despite a concomitant increase in glycolytic metabolic activity. Similar effect of SDH inhibition were demonstrated in pre-activated T cell. Interestingly, itaconic acid, an endogenous SDH inhibitor released from activated macrophages and dendritic cells, had no immunomodulator effect. Taken together, our findings demonstrate that SDH enzyme fitness is critical for mounting and maintaining appropriate activation and function of human T cells.

Topics & Concepts

Succinate dehydrogenaseFunction (biology)ChemistryCell biologyBiochemistryEnzymeBiologyCancer, Hypoxia, and MetabolismAdipose Tissue and MetabolismImmune cells in cancer